First Time Loading...

Urovo Technology Co Ltd
SZSE:300531

Watchlist Manager
Urovo Technology Co Ltd Logo
Urovo Technology Co Ltd
SZSE:300531
Watchlist
Price: 10.44 CNY 2.45% Market Closed
Updated: May 18, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

2.3B
-7%
Assets
Growth Rates:
1 Year
-4%
3 Years
+16%
5 Years
+97%
7 Years
+264%
10 Years
-
798m
+10%
Liabilities
Growth Rates:
1 Year
+13%
3 Years
+50%
5 Years
+65%
7 Years
+852%
10 Years
-
1.5B
-14%
Equity
Growth Rates:
1 Year
-11%
3 Years
+4%
5 Years
+118%
7 Years
+176%
10 Years
-

Balance Sheet Decomposition
Urovo Technology Co Ltd

2.3B
Assets
798m
Liabilities
2.3B
Assets
798m
Liabilities
Current Assets 1.9B
Cash & Short-Term Investments 1.2B
Receivables 352.6m
Other Current Assets 345.3m
Non-Current Assets 435.8m
Long-Term Investments 78.6m
PP&E 153.4m
Intangibles 174.9m
Other Non-Current Assets 28.9m
Current Liabilities 761.7m
Accounts Payable 164.3m
Accrued Liabilities 39.3m
Short-Term Debt 456.6m
Other Current Liabilities 101.6m
Non-Current Liabilities 36.3m
Long-Term Debt 24.5m
Other Non-Current Liabilities 11.9m

Balance Sheet
Urovo Technology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
35
77
191
324
361
553
634
790
899
934
Cash
0
0
0
0
0
1
0
790
599
341
Cash Equivalents
35
77
191
324
361
552
634
0
299
593
Short-Term Investments
0
0
0
0
3
20
10
2
95
277
Total Receivables
121
136
151
189
323
261
321
376
427
353
Accounts Receivables
110
119
139
166
276
211
281
347
386
324
Other Receivables
11
17
12
23
47
50
41
29
41
28
Inventory
78
121
144
133
260
282
273
306
321
299
Other Current Assets
18
13
138
17
48
89
94
53
47
46
Total Current Assets
252
347
624
663
996
1 206
1 333
1 526
1 789
1 909
PP&E Net
8
6
8
38
38
97
96
125
141
153
PP&E Gross
8
6
8
38
38
97
96
125
141
153
Accumulated Depreciation
6
8
9
12
15
22
27
43
51
54
Intangible Assets
0
1
1
2
4
34
26
19
16
45
Goodwill
0
0
0
87
85
484
474
474
387
130
Long-Term Investments
0
0
0
47
52
54
68
90
80
79
Other Long-Term Assets
10
11
11
12
18
25
28
25
31
29
Other Assets
0
0
0
87
85
484
474
474
387
130
Total Assets
270
N/A
365
+35%
644
+76%
849
+32%
1 193
+41%
1 901
+59%
2 024
+6%
2 259
+12%
2 444
+8%
2 345
-4%
Liabilities
Accounts Payable
22
36
30
49
103
109
139
165
134
164
Accrued Liabilities
4
8
9
15
24
30
35
36
44
39
Short-Term Debt
26
28
18
65
241
255
246
283
450
457
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
9
7
9
Other Current Liabilities
5
17
16
86
74
222
74
59
57
93
Total Current Liabilities
56
90
73
215
441
615
494
552
692
762
Long-Term Debt
0
0
0
0
0
0
0
8
3
24
Deferred Income Tax
0
0
0
0
0
4
2
1
2
8
Minority Interest
0
0
0
31
37
34
28
24
10
1
Other Liabilities
8
10
10
6
6
8
7
4
3
3
Total Liabilities
64
N/A
99
+56%
84
-16%
252
+201%
484
+92%
661
+36%
531
-20%
589
+11%
710
+21%
798
+12%
Equity
Common Stock
60
60
80
280
280
313
323
331
330
328
Retained Earnings
126
185
253
290
401
444
553
696
836
653
Additional Paid In Capital
21
21
227
27
27
483
617
682
668
647
Treasury Stock
0
0
0
0
0
0
0
40
100
82
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
206
N/A
266
+29%
560
+111%
597
+7%
709
+19%
1 240
+75%
1 493
+20%
1 670
+12%
1 734
+4%
1 547
-11%
Total Liabilities & Equity
270
N/A
365
+35%
644
+76%
849
+32%
1 193
+41%
1 901
+59%
2 024
+6%
2 259
+12%
2 444
+8%
2 345
-4%
Shares Outstanding
Common Shares Outstanding
210
210
280
280
280
313
323
330
324
324

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.